•  
  •  
 

Author ORCID Identifier

https://orcid.org/0009-0009-5535-8927

Corresponding Author

https://orcid.org/0009-0004-5404-5375

Abstract

Background: Coronavirus Disease – 2019 [COVID-19] infection is multisystem disease not restricted to the lungs it has negative impact on Cardiovascular system by activation of ACE-2 receptors causing plaque stability, vascular inflammation and MI. ECG and 2D ECHO is a simple bed side diagnostic test can be used to assess cardiovascular disease involvement in such patients. We aimed to find out ECG and 2D ECHO abnormalities of Covid – 19 patients. To Study relation of SARS-COV-2 infection and Prevalence of Cardiovascular disease.

Methods: We perform Cross Sectional study among 500 Post Covid – 19 patients [>20 and

Results: Out of Total 500 population Tachycardia abnormalities seen in 113 patients (22.6%), Rhythm abnormalities in 52 patients (10.4%), and QRS Complex in 36(9.2%), ST Segment Depression in 54(10.8%), Prolonged QT Interval in 22(4.4%), Poor R Wave in 36(7.2%), Chamber Morphology in 67(13.4%), Left Ventricular Systolic Function 159(31.8%), Left Ventricular Hypertrophy 104(20.8%), Aortic Jet Velocity 69(13.8%), Right Ventricular Systolic Pressure 102(26%).

Conclusion: In our study 302 (60.4%) of Post Covid – 19 patients have ECG and 2D ECHO changes. Patients with Severe Covid – 19 are at risk of Cardiac involvement in future. Periodic cardiac assessment of these patients is essential. ECG and 2D ECHO cardiography investigations are prerequisite in evaluation of cardiovascular disease. Our study has shown significant findings of ECG and 2D ECHO cardiogram hence our study concludes that ECG and 2D ECHO Cardiography must consider as an important diagnostic tools for evaluation of cardiovascular disease in Covid – 19 patients.

Publication Date

2025

Publisher

JSS Academy of Higher Education & Research

Conflict of Interest

NO conflict of interest

Keywords

Short PR Interval, ST Segment Depression, Chamber Morphology, Ejection Fraction, Prolong R Wave, Left Ventricular Hypertrophy

Word Count

2981

Creative Commons License

Creative Commons License
This work is licensed under a Creative Commons Attribution-Noncommercial-No Derivative Works 4.0 License.

Cover Page Footnote

Corresponding Author: Dr. Duurgaprasad.s,Associate professor, Department of General Medicine, [Government medical college ], [ongole], [Andhrapradesh], India. Email: durgaprasadsadupati@gmail.com | ORCID ID: [0009-0004-5404-5375] Funding: No external funding was received for this study. Conflict of Interest: The authors declare no conflict of interest. Author Contributions: All authors contributed equally to the study design, data collection, analysis, and manuscript preparation. Acknowledgments: We thank the patients and staff involved in this study during the COVID-19 pandemic.

Share

COinS
 
 

To view the content in your browser, please download Adobe Reader or, alternately,
you may Download the file to your hard drive.

NOTE: The latest versions of Adobe Reader do not support viewing PDF files within Firefox on Mac OS and if you are using a modern (Intel) Mac, there is no official plugin for viewing PDF files within the browser window.